Pancreatic cancer is characterized by constitutive activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway provoked by the prevailed KRAS mutation. Here, WNK2 is linked to familial pancreatic carcinoma.